| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.3 | 8e-15 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-13 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.28 | 7e-13 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.27 | 8e-13 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.32 | 1e-12 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.32 | 2e-12 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-12 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-12 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.25 | 5e-12 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | 0.34 | 6e-12 |